Because site-specific phosphorylation of Mecp2 contributes to these events and is a modulator of liver fibrosis, manipulation of enzymes regulating Mecp2 phosphorylation has potential for therapeutic targeting. The gene discussed is MECP2; the disease is Hepatic fibrosis.